BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 16557044)

  • 1. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.
    Mueller T; Mueller LP; Luetzkendorf J; Voigt W; Simon H; Schmoll HJ
    Tumour Biol; 2006; 27(2):71-83. PubMed ID: 16557044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine.
    Albany C; Hever-Jardine MP; von Herrmann KM; Yim CY; Tam J; Warzecha JM; Shin L; Bock SE; Curran BS; Chaudhry AS; Kim F; Sandusky GE; Taverna P; Freemantle SJ; Christensen BC; Einhorn LH; Spinella MJ
    Oncotarget; 2017 Jan; 8(2):2949-2959. PubMed ID: 27936464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin hypersensitivity of testicular germ cell tumors is determined by high constitutive Noxa levels mediated by Oct-4.
    Gutekunst M; Mueller T; Weilbacher A; Dengler MA; Bedke J; Kruck S; Oren M; Aulitzky WE; van der Kuip H
    Cancer Res; 2013 Mar; 73(5):1460-9. PubMed ID: 23302226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapeutic sensitivity of testicular germ cell tumors under hypoxic conditions is negatively regulated by SENP1-controlled sumoylation of OCT4.
    Wu YC; Ling TY; Lu SH; Kuo HC; Ho HN; Yeh SD; Shen CN; Huang YH
    Cancer Res; 2012 Oct; 72(19):4963-73. PubMed ID: 23002208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to Cisplatin and poly (adp-ribose) polymerase inhibition.
    Cavallo F; Graziani G; Antinozzi C; Feldman DR; Houldsworth J; Bosl GJ; Chaganti RS; Moynahan ME; Jasin M; Barchi M
    PLoS One; 2012; 7(12):e51563. PubMed ID: 23251575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
    Spierings DC; de Vries EG; Vellenga E; de Jong S
    Cell Death Differ; 2003 Jul; 10(7):808-22. PubMed ID: 12815464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-Induced Depletion of OCT4-Positive Cancer Stem Cells in a Mouse Model of Malignant Testicular Cancer.
    Pierpont TM; Lyndaker AM; Anderson CM; Jin Q; Moore ES; Roden JL; Braxton A; Bagepalli L; Kataria N; Hu HZ; Garness J; Cook MS; Capel B; Schlafer DH; Southard T; Weiss RS
    Cell Rep; 2017 Nov; 21(7):1896-1909. PubMed ID: 29141221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological evidence for the existence of germ cell tumor cells showing embryonal carcinoma morphology but lacking OCT4 expression and cisplatin sensitivity.
    Mueller T; Mueller LP; Holzhausen HJ; Witthuhn R; Albers P; Schmoll HJ
    Histochem Cell Biol; 2010 Aug; 134(2):197-204. PubMed ID: 20532795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.
    Selfe J; Goddard NC; McIntyre A; Taylor KR; Renshaw J; Popov SD; Thway K; Summersgill B; Huddart RA; Gilbert DC; Shipley JM
    J Pathol; 2018 Feb; 244(2):242-253. PubMed ID: 29160922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.
    Mueller T; Voigt W; Simon H; Fruehauf A; Bulankin A; Grothey A; Schmoll HJ
    Cancer Res; 2003 Jan; 63(2):513-21. PubMed ID: 12543810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of vitamin D on cisplatin sensitivity in testicular germ cell cancer-derived cell lines and in a NTera2 xenograft model.
    Jørgensen A; Blomberg Jensen M; Nielsen JE; Juul A; Rajpert-De Meyts E
    J Steroid Biochem Mol Biol; 2013 Jul; 136():238-46. PubMed ID: 23098692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seladin-1 and testicular germ cell tumours: new insights into cisplatin responsiveness.
    Nuti F; Luciani P; Marinari E; Erdei E; Bak M; Deledda C; Rosati F; Mazzinghi B; Danza G; Stoop H; Looijenga LH; Peri A; Serio M; Krausz C
    J Pathol; 2009 Dec; 219(4):491-500. PubMed ID: 19844922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis regulation and spontaneous apoptosis index of testicular germ cell tumors are associated with differentiation and resistance to systemic treatment.
    Mandoky L; Szende B; Géczi L; Bodrogi I; Kásler M; Bak M
    Anticancer Res; 2008; 28(3A):1641-9. PubMed ID: 18630521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.
    Rudolph C; Melau C; Nielsen JE; Vile Jensen K; Liu D; Pena-Diaz J; Rajpert-De Meyts E; Rasmussen LJ; Jørgensen A
    Cell Oncol (Dordr); 2017 Aug; 40(4):341-355. PubMed ID: 28536927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting DNA damage repair, p53-mediated apoptosis and cisplatin sensitivity in germ cell tumors.
    Cavallo F; Feldman DR; Barchi M
    Int J Dev Biol; 2013; 57(2-4):273-80. PubMed ID: 23784838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and roles of system L amino acid transporters in human embryonal carcinoma cells.
    Chatsirisupachai K; Kitdumrongthum S; Panvongsa W; Janpipatkul K; Worakitchanon W; Lertjintanakit S; Wongtrakoongate P; Chairoungdua A
    Andrology; 2020 Nov; 8(6):1844-1858. PubMed ID: 32741077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Mechanisms of Resistance in Testicular Germ Cell Tumors - clinical Implications.
    Kalavska K; Conteduca V; De Giorgi U; Mego M
    Curr Cancer Drug Targets; 2018; 18(10):967-978. PubMed ID: 29295694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of N-cadherin in proliferation, migration, and invasion of germ cell tumours.
    Bremmer F; Schallenberg S; Jarry H; Küffer S; Kaulfuss S; Burfeind P; Strauß A; Thelen P; Radzun HJ; Ströbel P; Honecker F; Behnes CL
    Oncotarget; 2015 Oct; 6(32):33426-37. PubMed ID: 26451610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines.
    Perry J; Powles T; Shamash J; Veerupillai A; McGrowder E; Noel E; Lu YJ; Oliver T; Joel S
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):925-33. PubMed ID: 19263053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embryonal carcinoma.
    Kerley-Hamilton JS; Pike AM; Li N; DiRenzo J; Spinella MJ
    Oncogene; 2005 Sep; 24(40):6090-100. PubMed ID: 15940259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.